| Autor: |
Watson NW; Harvard Medical School, Boston, MA; Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA., Dicks AB; Harvard Medical School, Boston, MA; Department of Medicine, Division of Cardiology, Massachusetts General Hospital, Boston, MA., Carroll BJ; Harvard Medical School, Boston, MA; Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA., Schmaier A; Harvard Medical School, Boston, MA; Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA., Secemsky EA; Harvard Medical School, Boston, MA; Department of Medicine, Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA; Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA. Electronic address: esecemsk@bidmc.harvard.edu. |
| Abstrakt: |
Competing Interests: Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: B. J. C. reports consulting for Reliant Medical and Janssen and receiving Institutional research support from Bristol Myers Squibb. E. A. S. reports grant funding from NIH/NHLBI (K23HL150290), the US Food & Drug Administration, BD, Boston Scientific, Cook, CSI, Laminate Medical, Medtronic and Philips and consulting and speaking fees from Abbott, Bayer, Becton, Dickinson, and Company, Boston Scientific, Cook, Cordis, Cardiovascular Systems, Inc., Inari, Medtronic, Philips, Shockwave and VentureMed. None declared (N. W. W., A. B. D., A. S.). |
